Phasix ST Umbilical Hernia Patch— 510(k) K243241

Substantially Equivalent

Davol, Inc., A Subsidiary of C.R. Bard, Inc.

FDA 510(k) clearance K243241 for Phasix ST Umbilical Hernia Patch, Substantially Equivalent on 2025-02-19. Applicant: Davol, Inc., A Subsidiary of C.R. Bard, Inc..

Clearance details

Applicant: Davol, Inc., A Subsidiary of C.R. Bard, Inc.
Product code: Code OWT
Advisory panel: General, Plastic Surgery
Date received: 2024-10-10
Decision date: 2025-02-19
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Warwick, RI, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code OWT

product code OWT

Death: 3
Injury: 396
Total: 399

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.